DanielM.QuirkMD

PubMed

• 8 citations
  Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments.
  Scott D. Lee, Raina Shivashankar, Daniel Quirk, Haiying Zhang, Jean Baptiste Telliez, John Andrews, Amy Marren, Arnab Mukherjee, Edward V. Loftus> ;Journal of Clinical Gastroenterology. 2021 Mar 1
• 12 citations
  Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program.
  Gary R. Lichtenstein, Gerhard Rogler, Matthew A. Ciorba, Chinyu Su, Gary Chan, Ronald Pedersen, Nervin Lawendy, Daniel Quirk, Chudy I. Nduaka, Andrew John Thorpe, Juli...> ;Inflammatory Bowel Diseases. 2021 May 17
• 13 citations
  Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.
  Bruce E. Sands, Jean-Frederic Colombel, Christina Ha, Michel Farnier, Alessandro Armuzzi, Daniel Quirk, Gary S. Friedman, Kenneth Kwok, Leonardo Salese, Chinyu Su, Pam...> ;Inflammatory Bowel Diseases. 2021 May 17
• 6 citations
  Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis.
  Millie D Long, Russell D Cohen, Timothy W Smith, Marco DiBonaventura, David Gruben, Danielle Bargo, Leonardo Salese, Daniel Quirk> ;Digestive Diseases. 2022 Jan 1
• 267 citations
  Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.
  Patrícia O. Guimarães, Daniel Quirk, Remo H. Furtado, Lilia N. Maia, José F. Saraiva, Murillo Oliveira Antunes, Roberto Kalil Filho, Vagner Madrini Junior, Alexandre d...> ;The New England Journal of Medicine. 2021 Jul 29
• 29 citations
  Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis
  William J. Sandborn, Laurent Peyrin-Biroulet, Daniel Quirk, Wenjin Wang, Chudy I. Nduaka, Arnab Mukherjee, Chinyu Su, Bruce E. Sands> ;Clinical Gastroenterology and Hepatology. 2020 Oct 27
• 16 citations
  Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis.
  Jean-Frederic Colombel, Mark T. Osterman, Andrew John Thorpe, Leonardo Salese, Chudy I. Nduaka, Haiying Zhang, Nervin Lawendy, Gary S. Friedman, Daniel Quirk, Chinyu S...> ;Clinical Gastroenterology and Hepatology. 2020 Oct 9
• 5 citations
  Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States.
  Millie D. Long, Timothy W. Smith, Marco DiBonaventura, David Gruben, Danielle Bargo, Leonardo Salese, Daniel Quirk> ;Inflammatory Bowel Diseases. 2020 May 12
• 28 citations
  Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe.
  Alessandro Armuzzi, Marco DiBonaventura, M. Tarallo, James Lucas, Daniel Bluff, Benjamin Hoskin, Danielle Bargo, Joseph C. Cappelleri, Daniel Quirk, Leonardo Salese> ;Plos One. 2020 Jan 16
• 59 citations
  Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis.
  Bruce E. Sands, Pam R. Taub, Alessandro Armuzzi, Gary S. Friedman, Michele Moscariello, Nervin Lawendy, Ronald Pedersen, Gary Chan, Chudy I. Nduaka, Daniel Quirk, Leon...> ;Clinical Gastroenterology and Hepatology. 2020 Jan 1
• 106 citations
  Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme
  William J. Sandborn, Julián Panés, Bruce E. Sands, Walter Reinisch, Chinyu Su, Nervin Lawendy, Nana Koram, Haiyun Fan, Thomas V. Jones, Irene Modesto, Daniel Quirk, Si...> ;Alimentary Pharmacology & Therapeutics. 2019 Nov 1
• 6 citations
  The Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis.
  Bruce E. Sands, Adam S. Cheifetz, Chudy I. Nduaka, Daniel Quirk, Wenjin Wang, E Maller, Gary S. Friedman, Chinyu Su, Peter D.R. Higgins> ;Journal of Crohn's & Colitis. 2019 Sep 19
• 14 citations
  An economic evaluation of tofacitinib for the treatment of moderately-to-severely active ulcerative colitis: modeling the cost of treatment strategies in the United St...
  Sandra Milev, Marco DiBonaventura, Peter Quon, Jo Wern Goh, Jeffrey A Bourret, Kathleen Peeples-Lamirande, Arif Soonasra, Joseph C. Cappelleri, Daniel Quirk> ;Journal of Medical Economics. 2019 May 15
• 109 citations
  Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis
  Stephen B. Hanauer, Remo Panaccione, Silvio Danese, Adam S. Cheifetz, Walter Reinisch, Peter D.R. Higgins, Deborah A Woodworth, Haiying Zhang, Gary S. Friedman, Nervin...> ;Clinical Gastroenterology and Hepatology. 2019 Jan 1
• 124 citations
  A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.
  Douglas K. Rex, Raj Bhandari, Taddese Desta, Michael P. DeMicco, Cynthia Schaeffer, K.P. Etzkorn, Charles F. Barish, Ronald E. Pruitt, Brooks D. Cash, D. Quirk, Felix ...> ;Gastrointestinal Endoscopy. 2018 Sep 1
• 1 citations
  Synchronous gastric and duodenal metastases from head and neck squamous cell carcinoma: a unique presentation of upper gastrointestinal bleeding.
  Nicholas P. Tarangelo, Charles Kistler, Zachary Daitch, Wei Jiang, Daniel M. Quirk> ;Annals of Gastroenterology. 2018 Feb 8
• 1 citations
  Rectal Blue Nevus: Distinguishing Features of a Rare Entity.
  Neena Mohan, Christina Tofani, Peter McCue, Daniel M. Quirk> ;ACG Case Reports Journal. 2016 Aug 1
• 12 citations
  Boerhaave's syndrome as an initial presentation of eosinophilic esophagitis: a case series.
  Whitney E. Jackson, Vaibhav Mehendiratta, Juan P. Palazzo, Anthony J. DiMarino, Daniel M. Quirk, Sidney Cohen> ;Annals of Gastroenterology. 2013 Mar 30
• 46 citations
  Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: a Phase I trial.
  Howard Safran, Thomas A. DiPetrillo, David A. Iannitti, Daniel Quirk, Paul A. Akerman, Dennis Cruff, William G. Cioffi, Samir A. Shah, Nadia Ramdin, Tyvin A. Rich> ;International Journal of Radiation Oncology, Biology, Physics. 2001 Nov 1
• 126 citations
  Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma.
  Howard Safran, Margaret M. Steinhoff, Shamlal Mangray, Ritesh Rathore, Thomas King, Li Chai, Katya Berzein, Todd M. Moore, David A. Iannitti, Philip T. Reiss, Terese P...> ;American Journal of Clinical Oncology. 2001 Oct 1
• 57 citations
  Paclitaxel and concurrent radiation for locally advanced pancreatic cancer
  Howard Safran, Todd M. Moore, David A. Iannitti, T. Dipetrillo, Paul A. Akerman, William G. Cioffi, David P. Harrington, Daniel Quirk, Ratesh Rathore, Dennis Cruff, Ja...> ;International Journal of Radiation Oncology, Biology, Physics. 2001 Apr 1
• 44 citations
  Lymphoepithelioma-like carcinoma of the colon in a patient with hereditary nonpolyposis colorectal cancer.
  Giovanni De Petris, Robert Lev, Daniel M. Quirk, Paul R. Ferbend, Janet R. Butmarc, Kojo S.J. Elenitoba-Johnson> ;Archives of Pathology & Laboratory Medicine. 1999 Aug 1
• 49 citations
  Guidelines for training in endoscopic ultrasound
  J. Van Dam, P. G. Brady, Martin L. Freeman, Frank G. Gress, Glenn W.W. Gross, E. Hassall, Robert H. Hawes, N. A. Jacobsen, R. A. Liddle, R. J. Ligresti, D. M. Quirk, J...> ;Gastrointestinal Endoscopy. 1999 Jun 1
• 63 citations
  Physician specialty and variations in the cost of treating patients with acute upper gastrointestinal bleeding
  Daniel Quirk, Michael J. Barry, Bernard Aserkoff, Daniel K. Podolsky> ;Gastroenterology. 1997 Nov 1
• 3 citations
  Physician specialty and cost-effectiveness of diverticulitis care: A difficult knot to untangle
  DM Quirk, MJ Barry> ;Gastroenterology. 1997 Jun 1
• Join now to see all